Interview with Sara Siegel, Health Care Leader, Deloitte Global
Inside the Landmark Hotel last week, conversations about healthcare sounded less like policy debates and more like glimpses into the future.
Healthcare leaders, policymakers, doctors and industry experts gathered in Nicosia for the OEB Health Conference, “Transforming Healthcare in Cyprus: New Trends, New Realities,” a first-of-its-kind event that set out to answer a big question: What will medicine actually look like in the near future? Organized by the Cyprus Employers & Industrialists Federation (OEB), in cooperation with the Cyprus Medical Association and supported by the Ministry of Health, the conference brought together local decision-makers and international voices to explore how technology, innovation and new ideas are reshaping healthcare, and how the patient experience itself is about to change.
But beneath discussions about policy reform and healthcare economics, one topic quietly dominated nearly every conversation: artificial intelligence.
And according to one of the conference’s keynote voices, the transformation is no longer theoretical.
It has already begun.
During the conference, I sat down with Sara Siegel, Deloitte’s Global Health & Human Services Sector Leader, whose work places her at the center of healthcare transformation across Europe and beyond.
With more than two decades advising healthcare systems, including extensive work with the UK’s National Health Service, Siegel has watched medical systems struggle with rising costs, staffing shortages, and growing patient expectations. For the past two years, she has also led Deloitte’s healthcare practice across North and South Europe, helping governments and providers navigate digital transformation.
Her message in Cyprus was clear: the biggest shift in medicine won’t be felt first by doctors or hospitals but by patients themselves.
“The most important change,” she said, “is how people will experience healthcare.”
For decades, patients have largely depended on whatever information their doctor shared during an appointment. AI, she explained, is about to fundamentally change that relationship.
Instead of being passive recipients of care, patients will increasingly become active participants, able to access reliable medical insights, understand treatment options, and interact with healthcare systems in ways that are clearer and more personalized.
In simple terms, healthcare will start speaking a language ordinary people understand.
Siegel illustrated the shift with a real-life example.
A colleague in the United States rushed his three-year-old daughter to an emergency room after she developed a sudden high fever and rash. While waiting for doctors, he entered her symptoms into a readily available consumer AI tool. The system suggested a rare bacterial infection affecting roughly one in 300,000 children.
After days of testing and consultations, doctors confirmed the exact same diagnosis.
Stories like this, she said, are becoming increasingly common, not because AI replaces doctors, but because it processes vast amounts of medical knowledge faster than any human could.
“One person’s lifetime of learning can’t match the collective knowledge AI can hold,” she said. “But it still needs the clinician’s judgment.”
For now, AI acts as a powerful assistant rather than a decision-maker, closer to an advanced diagnostic tool than a replacement for medical expertise.
Counterintuitively, Siegel believes the opposite will happen.
Healthcare systems today spend roughly 70% of their budgets on human labor. AI can reduce administrative burdens, shorten hospital stays, and help clinicians focus on complex cases instead of paperwork.
There is an upfront challenge: digitization. Countries that still rely heavily on paper records must first invest in structured data systems. But once that foundation exists, costs tend to fall while care becomes more consistent.
AI-driven clinical support could also reduce one of healthcare’s biggest hidden problems, variability.
Today, treatment outcomes can differ dramatically depending on which doctor a patient sees. AI tools can provide clinicians with global medical knowledge alongside their own experience, helping standardize care without removing human decision-making.
Six months ago, Siegel said, many clinicians feared AI would replace them.
Now, attitudes are shifting quickly.
Doctors increasingly use voice transcription tools, automated documentation, and digital assistants, realizing AI functions more like a new medical instrument than a competitor.
What technology still cannot replicate, she emphasized, is empathy, intuition, and the ability to interpret subtle human signals.
“The human connection remains essential,” she said.
For Cyprus, the conversation carries particular urgency.
Siegel believes smaller countries may actually have an edge in the coming healthcare revolution. With a population of just over one million, system-wide reforms can happen faster than in large bureaucratic systems like the UK’s NHS.
Cyprus, she noted, already has strong foundations: EU integration, internationally trained clinicians, and access to global knowledge networks.
The challenge now is mindset.
Rather than patching existing problems, she argues, countries like Cyprus have a rare opportunity to redesign healthcare from the ground up, integrating innovation early instead of retrofitting it later.
“Small countries have a huge opportunity right now,” she said. “The key is to be bold.”
If her predictions hold true, healthcare a decade from now will look almost unrecognizable.
Fewer hospital visits. More care delivered at home. Wearables, smartphones and everyday devices continuously monitoring health conditions. Simple eye scans capable of detecting early signs of diseases such as Alzheimer’s or cancer, technologies already emerging in parts of Europe.
Routine testing could move out of clinics and into households, turning prevention into the norm rather than the exception.
Hospitals, in this vision, become places for critical care, not the center of everyday medicine.
The OEB Health Conference aimed to spark dialogue about policy and reform. But its deeper takeaway may have been something broader: healthcare is entering a transition as profound as the digital revolution that reshaped banking, media and communication.
AI is not arriving someday.
It is quietly rewriting medicine now, changing how doctors work, how systems operate, and most importantly, how patients understand their own health.
For Cyprus, the question is no longer whether that future will arrive.
It’s whether the country chooses to lead it...or catch up later.
Published in knews.kathimerini.com
© 2026 Deloitte Limited
In this press release references to “Deloitte” are references to one or more of Deloitte Touche Tohmatsu Limited (“DTTL”), a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see www.deloitte.com/about for a detailed description of the legal structure of DTTL and its member firms. The information contained in this press release is correct at the time of going to press.
About Deloitte Cyprus:
Deloitte & Touche (M.E.) (DME) is an affiliated sublicensed partnership of Deloitte NSE LLP with no legal ownership to DTTL. Deloitte North South Europe LLP (NSE) is a licensed member of Deloitte Tohmatsu Limited.
Deloitte Limited is the sub-licensed affiliate of Deloitte NSE for Cyprus. Deloitte Limited is among the leading professional services firms in Cyprus, providing audit and assurance, consulting, financial advisory, risk advisory, tax and related services, as well as a complete range of services to businesses operating from Cyprus. For more information, please visit the Deloitte Cyprus’s website at www.deloitte.com/cy.
Deloitte Limited is a private limited liability company registered in Cyprus (Reg. No. 162812).
Offices: Nicosia, Limassol
About Deloitte:
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited (“DTTL”), its global network of member firms, and their related entities (collectively, the “Deloitte organisation”). DTTL (also referred to as “Deloitte Global”) and each of its member firms and related entities are legally separate and independent entities, which cannot obligate or bind each other in respect of third parties. DTTL and each DTTL member firm and related entity is liable only for its own acts and omissions, and not those of each other. DTTL, NSE and DME do not provide services to clients. Please see www.deloitte.com/about to learn more.
Deloitte provides leading professional services to nearly 90% of the Fortune Global 500® and thousands of private companies. Our people deliver measurable and lasting results that help reinforce public trust in capital markets and enable clients to transform and thrive. Building on its 180-year history, Deloitte spans more than 150 countries and territories. Learn how Deloitte’s approximately 460,000 people make an impact that matters at www.deloitte.com.
Press contact(s):
Lena Machlouzarides
Manager | Brand, Marketing & Eminence
Deloitte Limited
Tel: +357 22 360 597
lmachlouzarides@deloitte.com